Position in KMDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$281,848
New position
Shares Held
38,399
first reported quarter
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 51 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 21%
Shared 0%
None 79%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. KMDA ranks #25 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
2,604,559 | $24,300,533 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,826,234 | $18,262,340 | |
| 3 | ZTS |
Zoetis Inc.
|
252,429 | $18,139,545 | |
| 4 | VTRS |
Viatris Inc
|
924,858 | $14,686,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
722,863 | $11,587,493 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
317,401 | $7,811,236 | |
| 7 | HROW |
Harrow, Inc.
|
180,893 | $7,682,525 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
198,546 | $6,726,737 |
All Filings in KMDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,848 | 38,399 | Shares | Defined | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||